Clinical Trial

Optimizing Early Cesarean Scar Healing

Completed
View on ClinicalTrials.gov →
Summary
This randomized controlled trial compares hydrophilic methacrylate gel versus beta-sitosterol ointment for early cesarean section scar healing. Adult women who underwent cesarean delivery were randomly assigned to receive either hydrophilic methacrylate gel (n=58) or beta-sitosterol ointment (n=59). Scar outcomes were assessed by trained nurses blinded to treatment allocation and by patients at two time points approximately 12 days apart. The primary outcome was scar redness measured by the Vancouver Scar Scale. Secondary outcomes included pigmentation, pliability, scar height, and patient-reported measures including pain, itching, satisfaction, and treatment recommendation.
Trial Details
NCT Number NCT07547462
Lead Sponsor Hamad Medical Corporation
Conditions Cesarean Section Scar, Wound Healing
Enrollment 117 participants
Start Date 2023-12-15
Primary Completion 2024-10-08 (estimated)
Study Completion 2024-11-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-23